Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Sayaka Shimada , Maki Komiyama , Hiromichi Wada , et al Added: 3 years ago
Topic: 5. Secondary Prevention of Cardiovascular Disease. Introduction and Objectives It is reported that 3 months of professional smoking cessation treatment achieves an initial smoking cessation rate of 80%. However, a 1 year cessation rate decreases to approximately 50%. The most common causes of relapse are weight gain, stress, and nicotine withdrawal symptoms. Relapse prevention is… View more

Heart Failure
Author(s): Koji Hasegawa , Maki Komiyama , Yuko Takahashi Added: 3 years ago
Smoking is a strong risk factor for the development of arteriosclerotic cardiovascular disease (CVD). Quitting smoking is a cornerstone of improved cardiovascular health, reducing the risk of developing CVD and the risk of overall mortality.1 It is astonishing that 7–28% of patients with coronary heart disease still smoke, but around half of smokers are planning to quit.2,3 Because the habit is… View more

Prevention & Chronic Conditions
Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
Author(s): Marco Rossato , Angelo Di Vincenzo Added: 3 years ago
We read with interest the paper by Komiyama and Hasegawa on the need for smoking cessation as a public health measure to limit the coronavirus disease 2019 (COVID-19) pandemic.1 It seems obvious to reiterate that smoking cessation is advisable to reduce many other severe conditions, such as chronic lung and cardiovascular diseases and some types of cancer, which are leading causes of morbidity… View more

COVID-19
Author(s): Maki Komiyama , Hiromichi Wada , Hajime Yamakage , et al Added: 3 years ago
Best Poster Award Topic: 1. Clinical Cardiology Introduction and Objectives Vessel wall Inflammation promotes the destabilization of atherosclerotic plaques. The lectin-like oxidized low- density lipoprotein (LDL) receptor-1 (LOX-1) expressed by vascular cells and monocytes. LOX index is calculated by multiplying LOX-1 ligand containing apolipoprotein B level with the soluble LOX-1. A high… View more

Heart Failure

Prevention & Chronic Conditions
Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic
Author(s): Maki Komiyama , Koji Hasegawa Added: 3 years ago
The novel coronavirus disease 2019 (COVID-19) first occurred in December 2019 in Wuhan, Hubei Province, China, and has already evolved into a rapidly expanding pandemic. The WHO has declared COVID-19, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), to be a public health emergency of international concern.1 Until effective therapeutics and vaccines become available… View more

Standards & Guidelines

COVID-19
Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
Author(s): Maki Komiyama , Koji Hasegawa Added: 3 years ago
Thank you very much for your interesting and important comments on our review that discussed smoking cessation to limit the coronavirus disease 2019 (COVID-19) pandemic.1,2 As you pointed out, the reported number of hospitalised COVID-19 patients who are current or former smokers is small.3,4 One reason for this small number of smokers is that an unknown history of smoking may be treated as a non… View more

COVID-19
Electronic Cigarettes and Cardiovascular Risk: Caution Waiting for Evidence
Author(s): Domenico D’Amario , Stefano Migliaro , Josip A Borovac , et al Added: 3 years ago
The ancient rite of smoking dates back thousands of years, and tobacco smoking has been largely ingrained in our civilization since the arrival of Europeans to the Americas in the 16th century. For a long time, cigarette smoking was perceived as a symbol of wealth, glamour and sophistication, whereas nowadays it is largely recognised as the first preventable or modifiable cause of common diseases… View more

Prevention & Chronic Conditions
Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
Author(s): Maki Komiyama , Koji Hasegawa Added: 2 years ago

COVID-19
Author(s): Olusola A Orimoloye , Albert D Osei , SM Iftekhar Uddin , et al Added: 3 years ago
It often takes time to accumulate enough evidence to deem causal hypotheses plausible truths. Since the introduction of e-cigarettes about a decade ago, studies assessing their potential health effects have resulted in a weak evidence base for causal links to several important clinical outcomes.1 Specifically, according to the National Academies of Science, Engineering, and Medicine’s summary of… View more

Prevention & Chronic Conditions
Author(s): Gianluigi Savarese Added: 3 years ago
Cardiovascular (CV) disease is the leading cause of death worldwide.1 Age, sex and genetic factors have a major impact on CV risk. The importance of behavioural factors, such as tobacco and alcohol use, physical inactivity, unhealthy diet and obesity, is often neglected, although the implementation of lifestyle changes may be a cost-effective strategy for the prevention of CV diseases, also from… View more

Prevention & Chronic Conditions